Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?

BJU International

Volumn 96, Issue 6, 2005, Pages 773-776

  Boorjian, Stephen A ^a   Bianco Jr , Fernando J ^a   Scardino, Peter T ^a   Eastham, James A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Disease recurrence; Nomograms; Prostate cancer; Risk groups; Time to therapy

Indexed keywords

FLUTAMIDE; NILUTAMIDE;

ARTICLE; BLADDER CANCER; BRACHYTHERAPY; CANCER RECURRENCE; CYSTOSCOPY; CYTOLOGY; HUMAN; JAPAN; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TESTIS CANCER; UNITED KINGDOM; UNITED STATES;

AGED; BIOPSY; COHORT STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TIME FACTORS;

EID: 25844481533     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05763.x     Document Type: Article

References (16)

1. Catalona WJ, Smith DS, Ratliff TL, Basler JW. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993; 270: 948-54
2. Humphrey PA, Keetch DW, Smith DS, Shepherd DL, Catalona WJ. Prospective characterization of pathological features of prostatic carcinomas detected via serum prostate specific antigen based screening. J Urol 1996; 155: 816-20
3. Pound CR, Partin AW, Epstein JI, Walsh PC. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. Urol Clin North Am 1997; 24: 395-406
4. D'Amico AV, Whittington R, Malkowicz SB et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74
5. Beahrs OH, Henson DE, Hutter RVP. American Joint Committee on Cancer: Manual for Staging Cance, Fourth edn. Philadelphia: JB Lippincott, 1992
6. D'Amico AV, Cote K, Loffredo M, Renshaw AA, Schultz D. Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer. J Clin Oncol 2002; 20: 4567-73
7. Kattan MW, Eastham JA, Stapleton AM, Wheeler TM, Scardino PT. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 1998; 90: 766-71
8. Nguyen PL, Whittington R, Koo S et al. The impact of a delay in initiating radiation therapy on prostate-specific antigen outcome for patients with clinically localized prostate cancer. Proc Am Soc Clin One 2004; 381 (Suppl): Abstract 4503
9. Nam RK, Jewett MA, Krahn MD et al. Delay in surgical therapy for clinically localized prostate cancer and biochemical recurrence after radical prostatectomy. Can J Urol 2003; 10: 1891-8
10. Moul JD, Sun L, Amling CL et al. How long can radical prostatectomy (RP) safely be delayed? CPDR's experiences from 3324 cases. J Urol 2004; 171 (Suppl): 312
11. Khan MA, Mangold LA, Epstein JI, Boitnott JK, Walsh PC, Partin AW. Impact of surgical delay on long-term cancer control for clinically localized prostate cancer. J Urol 2004; 172: 1835-9
12. Robertson C, Robertson AG, Hendry JH et al. Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in radiotherapy of carcinoma of the larynx in four centers. Int J Radiat Oncol Biol Phys 1998; 40: 319-29
13. O'Rourke N, Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol) 2000; 12: 141-4
14. Sainsbury R, Johnston C, Haward B. Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis. Lancet 1999; 353: 1132-5
15. Roncoroni L, Pietra N, Violi V, Sarli S, Choua O, Peracchia A. Delay in diagnosis and outcome of colorectal cancer: a prospective study. Eur J Surg Oncol 1999; 25: 173-8
16. Epstein JI, Walsh PC, Carter HB. Dedifferentiation of prostate cancer grade with time in men followed expectantly for stage T1c disease. J Urol 2001; 166: 1688-91